Matthew McManus - 15 Aug 2024 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role: President - DGS
Signature: /s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
Issuer symbol: TECH
Transactions as of: 15 Aug 2024
Transactions value $: $0
Form type: 4/A - Amendment
Filing time: 03 Feb 2025, 16:38:53 UTC
Date Of Original Report: 19 Aug 2024
Previous filing: 05 Feb 2024
Next filing: 04 Feb 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TECH	Performance Restricted Stock Units	Award	$0	+15.8K		$0.00	15.8K	15 Aug 2024	Common Stock	15.8K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2	Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of performance restricted stock units being granted.